Literature DB >> 31953620

Melanotan II: a possible cause of renal infarction: review of the literature and case report.

Björn Peters1,2, Henrik Hadimeri3,4, Rebecka Wahlberg3, Henri Afghahi3,4.   

Abstract

Renal infarction is an uncommon condition resulting from an acute disruption of renal blood flow and it is potentially life-threatening disease. The cause and outcome of renal infarction is not well established and is frequently misdiagnosed or diagnosed late. Melanotan II is a non-selective melanocortin-receptor agonist and its effect on humans is an increasing of skin pigmentation, producing of spontaneous penile erection and sexual stimulation. Melanotan II inducing rhabdomyolysis and renal failure have been described previously. We present a review of Melanotan II and the possible effects of this drug on the kidneys by including a case of a renal infarction most likely attributed to Melanotan II. In the mechanism of renal injury with Melanotan II, thrombotic pharmacological influence and possible direct toxic effect on renal parenchyma must be considered.

Entities:  

Keywords:  Barbie drug; Kidney injury; Melanotan II; Renal infarction

Mesh:

Substances:

Year:  2020        PMID: 31953620      PMCID: PMC7148395          DOI: 10.1007/s13730-020-00447-z

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  20 in total

1.  Eruptive melanocytic naevi following melanotan injection.

Authors:  P Cousen; G Colver; I Helbling
Journal:  Br J Dermatol       Date:  2009-07-02       Impact factor: 9.302

2.  Central dopamine-oxytocin-adrenocorticotropin link in the expression of yawning and penile erection.

Authors:  A Argiolas; M R Melis; G L Gessa
Journal:  Ann Ist Super Sanita       Date:  1988       Impact factor: 1.663

3.  Melanotan II injection resulting in systemic toxicity and rhabdomyolysis.

Authors:  Michael E Nelson; Sean M Bryant; Steven E Aks
Journal:  Clin Toxicol (Phila)       Date:  2012-11-05       Impact factor: 4.467

4.  Idiopathic renal infarction.

Authors:  Rob Bolderman; Raymond Oyen; Anton Verrijcken; Daniël Knockaert; Steven Vanderschueren
Journal:  Am J Med       Date:  2006-04       Impact factor: 4.965

Review 5.  Melanotropic peptides: more than just 'Barbie drugs' and 'sun-tan jabs'?

Authors:  E A Langan; Z Nie; L E Rhodes
Journal:  Br J Dermatol       Date:  2010-06-09       Impact factor: 9.302

6.  Melanocortin receptor agonists, penile erection, and sexual motivation: human studies with Melanotan II.

Authors:  H Wessells; N Levine; M E Hadley; R Dorr; V Hruby
Journal:  Int J Impot Res       Date:  2000-10       Impact factor: 2.896

7.  A glimpse into the underground market of melanotan.

Authors:  Daniel J Callaghan Iii
Journal:  Dermatol Online J       Date:  2018-05-15

8.  alpha-Melanocyte-stimulating hormone-induced eruptive nevi.

Authors:  Adela R Cardones; James M Grichnik
Journal:  Arch Dermatol       Date:  2009-04

9.  Acute renal embolism. Forty-four cases of renal infarction in patients with atrial fibrillation.

Authors:  Natasha Hazanov; Marina Somin; Malka Attali; Nick Beilinson; Michael Thaler; Meir Mouallem; Yasmin Maor; Nurit Zaks; Stephen Malnick
Journal:  Medicine (Baltimore)       Date:  2004-09       Impact factor: 1.889

Review 10.  Drug-induced thrombosis--experimental, clinical, and mechanistic considerations.

Authors:  Yuval Ramot; Abraham Nyska
Journal:  Toxicol Pathol       Date:  2007-02       Impact factor: 1.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.